The COVID-19 pandemic has created unexpected challenges for many populations, and people with opioid use disorder are no exception. Jeanmarie Perrone, MD and Utsha Khatri, MD comment on the ways that COVID-19 have made it more difficult for people to acquire medications for opioid use disorder (MOUD) during this pandemic.